ClinicalTrials.gg
RecruitingNCT06754007Updated Feb 14, 2025

Rapid Optimisation of Performance Enhancement and Skill (ROPES)

An interventional study of ROPES Training Programme in Sedentary Lifestyle, sponsored by Singapore General Hospital. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-02-14.

Sponsored by Singapore General Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
21 Years to 70 Years
Sex
All
01

Study summary

Despite innate knowledge of the benefits of regular physical activity, healthcare workers are just as physically inactive as the general population. Physical activity interventions delivered at the workplace seem perfect to improve the health of this large population.

The aim of the study is to deliver an efficacious, minimal time impost training program targeted at optimising health benefit while overcoming time-related barriers to initial uptake of regular exercise.

Read the detailed description

To evaluate the effectiveness of a 4-week, easily accessible, time-optimised exercise program (ROPES - Rapid Optimisation of Performance Enhancement and Skill) for healthcare workers.

60 staff recruited from Singapore General Hospital (SGH) will be randomly assigned into 2 groups, CONTROL or ROPES group. The ratio to intervention and control group is at 1:1. The staff will be assigned to each group respectively.

02

Conditions studied

  • Sedentary Lifestyle

Browse trials for

Keywords

  • Sedentary
  • healthcare workers
03

In context

Sedentary Behavior

368 studies on the registry are indexed under Sedentary Behavior; 165 are open to participants now.

This study's planned enrollment of 60 is below the median of 70 across 314 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

Singapore General Hospital is the lead sponsor of 270 studies on the registry; 58 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age group: 21 - 70 years old
  • All participants must be free of musculoskeletal, surgical and/or neurological injury in the past 6 months.
  • Participants not engaged actively in regular exercise i.e. exercises less than once a week and at a duration less than 30 mins per session.
  • Healthy with stable management of any existing diabetes, cholesterol and/or hypertension.
  • They should have no issues with the Physical Activity Readiness Questionnaire (PAR-Q)

Exclusion criteria

Exclusion Criteria:

  • Participants under the age of 21 or over the age of 70
  • Newly diagnosed diabetes/metabolic syndrome/high cholesterol or uncontrolled high BP >160 mmHg and under medical supervision.
  • Subjects with cardiovascular conditions and on beta-blockers.
  • Subjects who are pregnant or with recent (\< 3 months) diagnosis of a medical condition, especially cardiac-related conditions.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Control

    30 participants will be randomised into the CONTROL group and will continue to perform their normal activities. They will only be required to keep a log of their exercise intensity for each week over the 4-week period and record them on an online diary. The exercise log/diary consists of type of exercise, e.g. resistance or aerobic and duration of exercise session.

  • Experimental
    ROPES

    The intervention is a 4-week training exercise program conducted by trained Physiotherapists.

    Procedure: ROPES Training Programme

Interventions

  • ProcedureROPES Training Programme

    ROPES is a training programme that involves resistance training, whole-body exercises and HIIT aerobic sessions with each session lasting no longer than 45 minutes.

06

What researchers measure

Primary outcomes

  1. Physical work capacity

    A standard physical work capacity test based on the linear relationship between heart rate, power output and oxygen consumption will estimate the work capacity. The higher the heart rate, the better the physical work capacity. Minimum value of heart rate is 155 bpm and maximum value is 199 bpm.

    Time frame: From enrollment to the end of study at 8 weeks

Secondary outcomes

  1. Muscular Strength

    Handgrip strength will be measured using a hand-held dynamometer to determine functional strength.

    Time frame: From enrollment to the end of study at 8 weeks

  2. BMI

    Height and weight will be measured on a body fat analyser and will be combined to report the BMI in kg/m\^2.

    Time frame: From enrollment to the end of study at 8 weeks

  3. Body Fat

    Body fat will be measured on a body composition analyser and will be reported in percentage %.

    Time frame: From enrollment to the end of study at 8 weeks

07

Study locations

1 of 1 sites recruiting
  • Singapore General Hospital
    Singapore, Singapore
    • Celia Ia Choo Tan, PhD (Dept of Surgery) · Contact · celia.tan.i.c@singhealth.com.sg · +65 63265281
    • Celia Ia Choo Tan, PhD (Dept of Surgery) · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06754007
Responsible party
Celia Tan Ia Choo (Senior Principal Physiotherapist, Singapore General Hospital) — Principal investigator
First posted
Dec 31, 2024
Start date
Jan 2, 2025
Primary completion
Jun 2025 (estimated)
Completion
Aug 2025 (estimated)
Last update
Feb 14, 2025

Study contacts

Celia Ia Choo Tan, PhD (Dept of Surgery)
Contact
celia.tan.i.c@singhealth.com.sg
+65 63265281

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion